Xeris Biopharma Holdings, Inc. Financial Ratios — XERS Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-67.63	-72.81	-109.67	-67.98	-52.95	-29.18	-18.66	-16.99	0.16
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-7.29
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.69
Gross Margin (%)	99.26	99.74	100	41.11	54.35	73.14	79.47	82.52	81.86	85.41
EBITDA Margin (%)	-1,220	-1,696.92	-2,435.99	-4,456.36	-401.66	-228.43	-62.83	-18.82	-10.35	12.88
Operating Margin (%)	-1,230.79	-1,711.38	-2,449.2	-4,495.96	-408.84	-232.22	-74.32	-26.85	-16.57	8.53
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	65.94
Pretax Margin (%)	-1,228.74	-1,706.56	-2,479.57	-4,630.35	-446.54	-247.48	-87.15	-38.74	-28.12	0.19
Profit Margin (%)	-1,228.74	-1,706.56	-2,479.57	-4,613.52	-446	-247.48	-85.86	-37.98	-27	0.19
Net Income to Common Margin (%)	-1,228.74	-1,706.56	-2,479.57	-4,613.52	-446	-247.48	-85.86	-37.98	-27	0.19
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	32	58	87	88	198	229	271	258
ST Debt	- -	- -	- -	- -	- -	- -	2	3	21	6
LT Debt	- -	- -	32	58	87	88	196	226	250	252
Total Debt/EBITDA	- -	- -	-0.54	-0.48	-1.06	-0.78	-2.86	-7.43	-12.91	6.87
Net Debt/EBITDA	2.46	1.59	0.23	-0.32	-0.6	-0.18	-0.94	-4	-7.63	2.91
Total Debt/EBIT	- -	- -	-0.54	-0.48	-1.04	-0.76	-2.42	-5.21	-8.07	10.37
Net Debt/EBIT	2.44	1.58	0.23	-0.32	-0.59	-0.18	-0.79	-2.81	-4.77	4.39
EBITDA to Interest Expense	-6,557.5	-13,202	-23.19	-16.93	-7.7	-15.78	-4.91	-1.16	-0.69	1.29
EBITDA-CapEx/Interest Expense	-6,575	-13,552	-23.79	-16.93	-7.7	-15.78	-4.91	-1.16	-0.69	1.29
EBIT to Interest Expense	-6,615.5	-13,314.5	-23.32	-17.09	-7.84	-16.04	-5.81	-1.65	-1.1	0.86
Interest Expense	- -	- -	3	7	11	7	14	27	30	29
Common Equity/Total Assets	-101.48	-134.64	-100.53	-225.94	-211.99	-151.17	-161.02	-191.26	-207.96	-175.03
Long-Term Debt/Equity (%)	- -	- -	42.29	403.89	257.76	92.48	434.81	- -	- -	1,839.92
Long-Term Debt/Capital (%)	- -	- -	-35.92	-31.02	-34.76	-23.67	-55.08	-58.2	-62.5	-60.96
Long-Term Debt/Total Assets (%)	- -	- -	26.57	53.5	54.68	28.94	57.03	69.96	77.47	65.67
Total Debt/Equity (%)	- -	- -	42.29	403.89	257.76	92.48	438.31	-3,379.4	-916.59	1,885.44
Total Debt/Capital (%)	- -	- -	-35.92	-31.02	-34.76	-23.67	-55.52	-59.1	-67.79	-62.46
Total Debt/Total Assets (%)	- -	- -	26.57	53.5	54.68	28.94	57.49	71.04	84.02	67.3
Net Debt to Equity	101.05	72.7	-18.34	268.68	146.39	21.84	144.09	-1,820.75	-541.91	798.4
Net Debt/Capital (%)	48.67	40.97	10.28	-18.7	-17.16	-4.73	-13.6	-27.12	-34	-20.85
EBITDA	-13	-26	-59	-121	-82	-113	-69	-31	-21	38
EBITDA-CapEx	-13	-27	-61	-121	-82	-113	-69	-31	-21	38
Operating Income (Loss)	-13	-27	-59	-122	-84	-115	-82	-44	-34	25

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	12.77	8.65	11.07	2.76	4.74	1.3	1.66	0.76	0.71	1.01
Current Ratio	13.13	9.06	11.59	3.2	5.4	1.8	2.54	1.64	1.67	2.19
Quick Ratio	12.81	8.9	11.35	2.94	4.99	1.52	2.08	1.17	1.12	1.48
CFO/Avg Current Liab	- -	-6.68	-7.49	-5.56	-2.9	-1.78	-1.35	-0.56	-0.38	0.27
Common Equity/Total Assets	-101.48	-134.64	-100.53	-225.94	-211.99	-151.17	-161.02	-191.26	-207.96	-175.03
Long-Term Debt/Equity (%)	- -	- -	42.29	403.89	257.76	92.48	434.81	- -	- -	1,839.92
Long-Term Debt/Capital (%)	- -	- -	-35.92	-31.02	-34.76	-23.67	-55.08	-58.2	-62.5	-60.96
Long-Term Debt/Total Assets (%)	- -	- -	26.57	53.5	54.68	28.94	57.03	69.96	77.47	65.67
Total Debt/Equity (%)	- -	- -	42.29	403.89	257.76	92.48	438.31	-3,379.4	-916.59	1,885.44
Total Debt/Capital (%)	- -	- -	-35.92	-31.02	-34.76	-23.67	-55.52	-59.1	-67.79	-62.46
Total Debt/Total Assets (%)	- -	- -	26.57	53.5	54.68	28.94	57.49	71.04	84.02	67.3
CFO/Total Liabilities	-24.57	-23.98	-126.12	-110.36	-64.25	-45.68	-34.37	-14.28	-10.49	7.74
CFO/CapEx	-459.63	-35.23	-37.27	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-1.59	-2.76	0.81	-5.01	-2.63	-5.32	-3.62	-3.47	-2.97	0.54

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	2.39	4.04	1.16	3.53	4.08	4.57	4.68	5.1	6.38
Days Sales Outstanding	- -	152.47	90.31	314.65	103.31	89.54	79.93	77.97	71.55	57.2
Inventory Turnover	- -	- -	- -	1.47	1.77	1.01	1.06	0.9	0.85	0.73
Days Inventory Outstanding	- -	- -	- -	247.74	206	362.74	345.53	405.03	431.14	500.95
Accounts Payable Turnover	- -	- -	- -	1.17	3.56	3.83	4.32	5.29	6.66	23.51
Accounts Payable Turnover Days	- -	150,151.88	- -	312.41	102.64	95.2	84.42	69.04	54.77	15.53
Cash Conversion Cycle	- -	-149,999.4	- -	249.98	206.67	357.08	341.04	413.96	447.92	542.61
Inventory to Cash Days	- -	152.47	- -	66.91	-102.69	-273.2	-265.6	-327.06	-359.6	-443.75
Inventories	- -	- -	- -	2	8	18	25	39	48	69
Raw Materials	- -	- -	- -	1	3	5	7	17	32	38
Work In Process	- -	- -	- -	1	4	7	11	11	11	11
Finished Goods	- -	- -	- -	- -	1	5	6	10	5	19
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	205	184	210	232	180	324	498	1,259
- Cash & Cash Equivalents	32	42	46	20	38	67	122	67	72	111
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	32	58	87	88	198	229	271	258
Enterprise Value	-32	-42	124	167	163	217	256	480	697	1,406
Total Capital	-34	-61	-89	-188	-250	-372	-357	-388	-400	-413
Total Debt/Capital (%)	- -	- -	-35.92	-31.02	-34.76	-23.67	-55.52	-59.1	-67.79	-62.46
Total Debt / EV	- -	- -	0.26	0.35	0.53	0.41	0.77	0.48	0.39	0.18
EV/Sales	- -	- -	51.19	61.29	7.98	4.38	2.33	2.93	3.43	4.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	37.42
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	56.49
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.37
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.37
Diluted Market Cap	- -	- -	205	184	210	232	180	324	498	1,356
Diluted Enterprise Value	-32	-42	191	223	259	252	256	485	697	1,503
EV per Share	- -	- -	10.3	6.39	3.82	2.75	1.89	3.49	4.75	8.77
TTM Sales	1	2	2	3	20	50	110	164	203	292
TTM EBITDA	-13	-26	-59	-121	-82	-113	-69	-31	-21	38
TTM Operating Income	-13	-27	-59	-122	-84	-115	-82	-44	-34	25
TTM Cash Flow to Firm	-16	-25	-54	-97	-70	-88	-89	-21	-8	58
TTM Free Cash Flow to Firm	-16	-24	-52	-97	-70	-88	-89	-21	-8	58

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-3.74	-1.76	-2.6	-2.42	-1.75	-6.88	-13.45	47.37
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	56.49
Enterprise Value	-32	-42	124	167	163	217	256	480	697	1,406
Low Price	- -	- -	15.01	6.81	1.42	1.77	1.14	0.97	1.69	3.14
EV/Sales	- -	- -	51.19	61.29	7.98	4.38	2.33	2.93	3.43	4.82
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	37.42
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	2,273.17
Price/Earnings Average	- -	- -	-4.17	-2.22	-1.96	-2.28	-2.72	-4.39	-6.96	1,685.48
Price/Earnings High	- -	- -	-5.61	-3.93	-3.39	-5.11	-4.44	-6.79	-10.36	2,918.93
Price/Earnings Low	- -	- -	-3.01	-1.42	-0.66	-1.14	-1.63	-2.15	-4.52	909.27
Price/Book Value	- -	- -	-1.7	-0.75	-0.62	-0.5	-0.33	-0.52	-0.74	-1.88
Price/Book Value Average	- -	- -	-2.08	-1.13	-0.53	-0.61	-0.46	-0.44	-0.57	-1.39
Price/Book Value High	- -	- -	-2.79	-2	-0.92	-1.36	-0.76	-0.69	-0.85	-2.41
Price/Book Value Low	- -	- -	-1.5	-0.72	-0.18	-0.3	-0.28	-0.22	-0.37	-0.75
Price/Tangible Book Value	- -	- -	2.72	12.75	6.21	-3.92	-1.84	-2.32	-3.29	-12.95
Price/Tangible Book Value Average	- -	- -	3.32	19.31	5.3	-4.74	-2.62	-1.96	-2.52	-9.6
Price/Tangible Book Value High	- -	- -	4.47	34.15	9.14	-10.62	-4.28	-3.03	-3.75	-16.63
Price/Tangible Book Value Low	- -	- -	2.4	12.32	1.79	-2.37	-1.57	-0.96	-1.64	-5.18
Price/Sales	- -	- -	84.52	67.63	10.27	4.67	1.64	1.97	2.45	4.32
Price/Sales Average	- -	- -	103.44	102.42	8.76	5.65	2.34	1.67	1.88	3.2
Price/Sales High	- -	- -	139.1	181.1	15.11	12.65	3.81	2.58	2.8	5.54
Price/Sales Low	- -	- -	74.62	65.32	2.96	2.82	1.4	0.81	1.22	1.73
Price/Cash Flow	- -	- -	-3.64	-1.76	-2.6	-2.42	-1.75	-6.88	-13.45	43.99
Price/Cash Flow Average	- -	- -	-4.45	-2.67	-2.22	-2.93	-2.51	-5.81	-10.32	32.62
Price/Cash Flow High	- -	- -	-5.99	-4.72	-3.83	-6.57	-4.09	-8.99	-15.36	56.49
Price/Cash Flow Low	- -	- -	-3.21	-1.7	-0.75	-1.46	-1.5	-2.84	-6.71	17.6
Price/Free Cash Flow Average	- -	- -	-4.58	-2.67	-2.22	-2.93	-2.51	-5.81	-10.32	35.12
Price/Free Cash Flow High	- -	- -	-6.15	-4.72	-3.83	-6.57	-4.09	-8.99	-15.36	60.83
Price/Free Cash Flow Low	- -	- -	-3.3	-1.7	-0.75	-1.46	-1.5	-2.84	-6.71	18.95
EV/Sales Average	- -	- -	97.73	116.67	11.18	6.07	3.03	2.65	2.86	3.7
EV/Sales High	- -	- -	133.4	195.35	17.53	13.07	4.5	3.57	3.78	6.04
EV/Sales Low	- -	- -	68.92	79.57	5.38	3.24	2.09	1.8	2.21	2.23
EV/EBITDA Average	2.46	1.59	-4.01	-2.62	-2.78	-2.66	-4.82	-14.1	-27.65	28.75
EV/EBITDA High	2.46	1.59	-5.48	-4.38	-4.36	-5.72	-7.17	-18.94	-36.53	46.93
EV/EBITDA Low	2.46	1.59	-2.83	-1.79	-1.34	-1.42	-3.33	-9.57	-21.31	17.31
EV/EBIT Average	2.44	1.58	-3.99	-2.59	-2.73	-2.61	-4.07	-9.88	-17.28	43.41
EV/EBIT High	2.44	1.58	-5.45	-4.35	-4.29	-5.63	-6.06	-13.28	-22.82	70.86
EV/EBIT Low	2.44	1.58	-2.81	-1.77	-1.32	-1.4	-2.82	-6.71	-13.31	26.14
Last Price	- -	- -	17	7.05	4.92	2.93	1.33	2.35	3.39	7.85
High Price	- -	- -	27.98	18.88	7.24	7.94	3.1	3.07	3.87	10.08
Enterprise Value Average	-32	-42	237	318	228	301	334	435	581	1,081
Enterprise Value High	-32	-42	323	532	358	648	497	584	768	1,764
Enterprise Value Low	-32	-42	167	217	110	161	231	295	448	651

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	19	19	21	27	60	125	136	138	149	166
Diluted Weighted Avg Shares	2	2	12	26	43	79	136	138	147	173
Basic Weighted Avg Shares	2	2	12	26	43	79	136	138	147	160
Revenue per Share	0.5	0.72	0.2	0.1	0.48	0.63	0.81	1.19	1.38	1.82
EBITDA per Share	-6.04	-12.17	-4.9	-4.65	-1.92	-1.43	-0.51	-0.22	-0.14	0.23
Operating Income per Share	-6.1	-12.27	-4.93	-4.69	-1.96	-1.46	-0.6	-0.32	-0.23	0.16
Basic EPS, GAAP	-6.09	-12.24	-4.99	-4.81	-2.14	-1.55	-0.7	-0.45	-0.37	- -
Basic EPS from Cont Ops	-6.09	-12.24	-4.99	-4.81	-2.14	-1.55	-0.7	-0.45	-0.37	- -
Diluted EPS, GAAP	-6.09	-12.24	-4.99	-4.81	-2.14	-1.55	-0.7	-0.45	-0.37	- -
Diluted EPS from Cont Ops	-6.09	-12.24	-4.99	-4.81	-2.14	-1.55	-0.7	-0.45	-0.37	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-7.41	-11.37	-4.67	-4	-1.89	-1.21	-0.76	-0.34	-0.25	0.18
Free Cash Flow per Basic Share	-7.43	-11.69	-4.8	-4	-1.89	-1.21	-0.76	-0.34	-0.25	0.18
Cash & Equivalents per Share	14.87	19.38	9.35	2.89	3.14	1.3	0.9	0.53	0.49	0.69
Book Value per Share	-15.69	-27.92	-10.02	-9.43	-7.91	-5.82	-4.09	-4.48	-4.58	-4.18
Tangible Book Value per Share	-14.72	-26.65	6.26	0.55	0.79	-0.75	-0.72	-1.01	-1.03	-0.61

Xeris Biopharma Holdings, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)